SCHEMBL30460552

SCHEMBL30460552

C[C@H]1COCCN1Cc1ccc(I)cc1

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 1/20 0.56
HIF1A Q16665 4/20 0.43
EPAS1 Q99814 4/20 0.43
GRM2 Q14416 3/20 0.41
ALDH1A1 P00352 2/20 0.41
PDE1B Q01064 1/20 0.41
HRH3 Q9Y5N1 4/20 0.40
CCNC P24863 1/20 0.40
CDK8 P49336 1/20 0.40
CNR2 P34972 1/20 0.40
KDM4E B2RXH2 1/20 0.39
PIK3CD O00329 1/20 0.39
PIK3R2 O00459 1/20 0.39
PIK3CA P42336 1/20 0.39
PIK3CB P42338 1/20 0.39
PIK3CG P48736 1/20 0.39
PIK3R5 Q8WYR1 1/20 0.39
PIK3R3 Q92569 1/20 0.39
CCR5 P51681 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30308375 1.00 LTA4H (0.56) LTA4HHIF1AEPAS1GRM2ALDH1A1
SCHEMBL14960477 0.86 LTA4H (0.57) LTA4HGRM2ALDH1A1PDE1BHRH3
SCHEMBL12214 0.86 LTA4H (0.57) LTA4HGRM2ALDH1A1PDE1BHRH3
SCHEMBL30508309 0.84 LTA4H (0.56) LTA4HGRM2ALDH1A1PDE1BHRH3
SCHEMBL8805178 0.84 LTA4H (0.56) LTA4HGRM2ALDH1A1PDE1BHRH3
SCHEMBL1005882 0.84 LTA4H (0.62) LTA4HCNR2PIK3CDPIK3R2PIK3CA
SCHEMBL1189298 0.84 LTA4H (0.62) LTA4HCNR2PIK3CDPIK3R2PIK3CA
SCHEMBL1005883 0.84 LTA4H (0.62) LTA4HCNR2PIK3CDPIK3R2PIK3CA
SCHEMBL22011076 0.82 LTA4H (0.54) LTA4HGRM2ALDH1A1PDE1BHRH3
SCHEMBL3509984 0.82 SMN1; SMN2 (0.59) LTA4HALDH1A1PDE1BHRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113754685-B Dihydrothiochromene pyrazole derivative, preparation method and application thereof in medicine 江苏恒瑞医药股份有限公司 2023-06-16 CN disclosed